PAS
ATXS

Point72 Asia (Singapore)’s Astria Therapeutics ATXS Stock Holding History

Point72 Asia (Singapore)’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.7K Sell
2,426
-9,543
-80% -$64.6K ﹤0.01% 729
2025
Q2 		$64.2K Buy
11,969
+5,254
+78% +$25.5K 0.01% 547
2025
Q1 		$35.9K Buy
+6,715
New +$47K 0.01% 621

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asia (Singapore)'s ATXS Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Astria Therapeutics (ATXS) stake by 80% in Q3 2025, selling an estimated $64.6K and leaving 2,426 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Point72 Asia (Singapore) first reported a position in ATXS in Q1 2025 and has held it in 3 quarters since. The position peaked at $64.2K in Q2 2025. 115 funds tracked by Wall St. Rank hold ATXS as of Q3 2025.

  • Point72 Asia (Singapore) held 2,426 shares of Astria Therapeutics worth $17.7K as of Q3 2025.
  • Point72 Asia (Singapore) sold 9,543 Astria Therapeutics shares in Q3 2025, an estimated $64.6K.
  • Astria Therapeutics made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #729 holding.
  • Point72 Asia (Singapore) first reported a position in Astria Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Astria Therapeutics position peaked at $64.2K in Q2 2025.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.